Screener
Praxis Precision Medicines, Inc. PRAX EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001689548-26-000083
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 96,904 | 76,067 | 202,764 | 150,795 |
| Loss from operations | (96,904) | (76,067) | (202,764) | (150,795) |
| Other income: | ||||
| Other income, net | 13,184 | 4,940 | 26,483 | 10,372 |
| Total other income | 13,184 | 4,940 | 26,483 | 10,372 |
| Net loss | $(83,720) | $(71,127) | $(176,281) | $(140,423) |
| Net loss per share attributable to common stockholders, basic and diluted | $(2.87) | $(3.31) | $(6.08) | $(6.60) |
| Weighted average common shares outstanding, basic and diluted | 29,131,375 | 21,474,827 | 29,008,351 | 21,266,490 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s EPS (diluted)?
- Praxis Precision Medicines, Inc. (PRAX) reported EPS (diluted) of -$2.87 in Q2 2026.
- How has Praxis Precision Medicines, Inc.'s EPS (diluted) changed year-over-year?
- Praxis Precision Medicines, Inc.'s EPS (diluted) increased by 13.3% year-over-year, from -$3.31 to -$2.87.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s EPS (diluted) has grown at a 36.2% compound annual growth rate (CAGR), from -$3.92 to -$13.47.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Praxis Precision Medicines, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude